Cor Vasa 2025, 67(4):443-448 | DOI: 10.33678/cor.2025.022

Effects of psychotropic medications on electrocardiography

Cenk Conkbayira, b, Abidin Akbirgünb, Ersan Berkselc, Didem Melis Oztasd, Burak Onale, Murat Ugurlucand, Ayse Ulgenf, g, Evren Hincalh
a Department of Cardiology, Faculty of Medicine, Near East University, Nicosia, Cyprus
b Baris Neurological and Mental Health Hospital, Nicosia, Cyprus
c Internal Medicine Department, Final University, Nicosia, Cyprus
d Department of Cardiovascular Surgery, Biruni University Faculty of Medicine, Istanbul, Turkey
e Department of Medical Pharmacology, Faculty of Medicine, Biruni University, Istanbul, Turkey
f Department of Biostatistics, Faculty of Medicine, Girne American University, Karmi, Cyprus
g Department of Mathematics, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom
h Department of Mathematics, Near East University, Nicosia, Cyprus

Background and aim: In recent years number of psychiatric patients has increased and psychotropic medications are becoming mostly used drugs. These drugs may affect cardiovascular system and we can check side effects with electrocardiography (ECG). In this study we aimed to analyse psychiatric medications' side effects on ECG. Objective and methods: Eighty-five patients included in this study have psychiatric diagnosis and have used psychoactive medications. Forty-five of these patients are male and 40 of them are female. Age varies from 23 to 94 years. ECG has been taken from the patients and PR duration, QRS duration, and corrected QT measured from each ECG. Twenty-two kinds of drugs (Akineton, Haldol, Zyprexia, Prolixin, Dogmatil, Risperdal, Diazem, Artane, Tegretol, Sulpirid, Cipram, Seroquel, Depaqin, Stelazin, Anafranil, Rivotril, Clopiksol, Largactil, Melleril, Epanutin, Nurodol, Desyrel) were analyzed statistically and PR duration, QRS duration, and cQT checked if there is an association with these drugs.

Results: All statistical analysis was performed with the IBM SPSS software package (version 24.0, IBM, Armong, NY, USA) at the 95% confidence interval level and p <0.05 level="" of="" significance="" quantitative="" variables="" were="" analyzed="" by="" friedman="" analysis="" for="" dependent="" group="" moreover="" the="" independent="" groups="" compared="" with="" mann-whitney="" u="" test="" in="" this="" study="" univariate="" analyses="" we="" found="" that="" haldol="" epanutin="" and="" nurodol="" may="" cause="" long="" pr="" risperdal="" seroquel="" clopiksol="" qrs="" duration="" depakin="" stelazin="" melleril="" qt="" on="" other="" hand="" multivariate="" tegretol="" is="" associated="" at="" a="" 0="" 05="" i="">p = 0.044). Diazem is effective for increasing the PR duration at a level of significance of 0.05 (p = 0.037) and Desyrel is effective for increasing the QTC time at a significance level of 0.05 (p = 0.023).

Conclusion: In this study we showed that among psychoactive medications, Nurodol is the most related drug that affects ECG and may cause long PR, long QRS duration and long QT. So while using psychiatric tablets physicians, nurses, families should be aware of cardiovascular side effects and regular ECG controls should be checked.

Keywords: ECG, Long QT, PR distance, Psychiatric drugs, QRS distance,

Received: December 18, 2024; Revised: January 29, 2025; Accepted: February 7, 2025; Prepublished online: June 2, 2012; Published: October 6, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Conkbayir C, Akbirgün A, Berksel E, Melis Oztas D, Onal B, Ugurlucan M, et al.. Effects of psychotropic medications on electrocardiography. Cor Vasa. 2025;67(4):443-448. doi: 10.33678/cor.2025.022.
Download citation

References

  1. Beach SR, Celano CM, Sugrue AM, et al. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics 2018;59:105-122. Go to original source...
  2. Brouillette J, Nattel S. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications. Can J Cardiol 2017;33:1577-1586. Go to original source... Go to PubMed...
  3. Ray WA, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225-235. Go to original source...
  4. Weeke P, Jensen A, Folke F, et al. Antipsychotics and associated risk of out-of-hospital cardiac arrest. Clin Pharmacol Ther 2014;96:490-497. Go to original source... Go to PubMed...
  5. Baldessarini RJ. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:2136-2137; author reply 2137-2138. Go to original source...
  6. Salden FCWM, Kutyifa V, Stockburger M, et al. Atrioventricular dromotropathy: evidence for a distinctive entity in heart failure with prolonged PR interval? Europace 2018;20:1067-1077. Go to original source... Go to PubMed...
  7. Yarmohammadi H, Wan EY, Biviano A, et al. Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: A real-world survey. Heart Rhythm O2 2022;4:171-179. Go to original source... Go to PubMed...
  8. Jackson LR, Ugowe F. Epidemiology and Outcomes Associated with PR Prolongation. Card Electrophysiol Clin 2021;13:661-669. Go to original source... Go to PubMed...
  9. Fusi C, Lazzerini PE, Cavigli L, et al. Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling. JACC Case Rep 2022;4:1098-1103. Go to original source... Go to PubMed...
  10. Schumacher K, Dagres N, Hindricks G, et al. Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes. Clin Res Cardiol 2017;106:767-775. Go to original source...
  11. Bogh SB, Kellett J, Ekelund U, Brabrand M. Relation of QRS Voltage and Prolonged QTc Interval to One-Year Mortality. Am J Cardiol 2020;134:138-142. Go to original source... Go to PubMed...
  12. Erdoğan T, Çetin M, Özyildiz AG, et al. Prolonged QRS independently predicts long-term all-cause mortality in patients with narrow QRS complex undergoing coronary artery bypass grafting surgery (9-year follow-up results). Kardiochir Torakochirurgia Pol 2020;17:117-122.
  13. Madias JE. Drug-induced QRS morphology and duration changes. Cardiol J 2008;15:505-509.
  14. Das B, Rawat VS, Ramasubbu SK, Kumar B. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients. Therapie 2019;74:599-609. Go to original source... Go to PubMed...
  15. Das B, Ramasubbu SK, Agnihotri A, et al. Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatient. Ther Adv Cardiovasc Dis 2021;15:17539447211058892. Go to original source...
  16. Khan Q, Ismail M, Haider I, Khan F. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study. Int J Clin Pharm 2017;39:1256-1264. Go to original source...
  17. Beach SR, Celano CM, Sugrue AM, et al. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics 2018;59:105-122. Go to original source...
  18. Vieweg WV, Wood MA, Fernandez A, et al. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Drugs Aging 2009;26:997-1012. Go to original source...
  19. Beach SR, Celano CM, Noseworthy PA, et al. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics 2013;54:1-13. Go to original source... Go to PubMed...
  20. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;62:1649-1671. Go to original source...
  21. Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf 2010;5:97-104. Go to original source...
  22. Manu P, Kane JM, Correll CU. Sudden deaths in psychiatric patients. J Clin Psychiatry 2011;72:936-941. Go to original source... Go to PubMed...
  23. Finsterer J, Fiorini AC, Scorza CA, Scorza FA. Sudden Death in Psychiatric Patients Is Multifactorial. J Clin Psychiatry 2020;82:20lr13623. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.